Lobbyists Serving on Advisory Committees – Where’s the Problem?

 

The new White House policy aimed at ridding federal advisory committees of lobbyists raises more questions than answers, as OMB Watch discusses in an article released yesterday.

No briefcaseThe White House says, “It is our aspiration that federally-registered lobbyists not be appointed to agency advisory boards and commissions,” but it’s not totally clear what problem the administration is trying to solve.

The policy, set forth in a blog post by White House special counsel Norm Eisen, is a continuation of the White House’s fetish for keeping lobbyists out of the Obama administration. White House officials have consistently failed to come to grips with two key truths: 1) some lobbyists serve the public interest, and their experience and expertise may make them ideal candidates for government service; and 2) Special interests employ non-lobbyists who could also be considered inappropriate for some government positions, making policies that only target lobbyists too easy to evade.

Moreover, while the federal advisory committee system does suffer from its fair share of ills, the presence of lobbyists isn’t one of them. Sometimes, members are appointed despite having a clear conflict of interest – a scientist having received funding from a company’s whose medical device is being examined by the FDA, for example. A committee’s advice can be compromised when it fails to distinguish between expert members expected to provide impartial advice and other members asked to represent stakeholder groups and provide opinion. (Increased transparency could go along way toward solving some of these problems. Requiring committee members to disclose lobbying activities is a more sensible reform than an outright ban.)

Banning lobbyists is not a reform often talked about, and it is not included in a federal advisory committee improvement bill currently under consideration in the House. The new White House policy is a solution in search of a problem.

One advisory committee likely to ignore the ban is the Homeland Security Advisory Council. One of the Council’s members is Kenneth “Chuck” Canterbury, president of the Fraternal Order of Police, the major union for police officers. Among other things, the Council is to provide “[r]ecommendations for the development of strategies and policies that will further the Department’s ability to prevent, protect against, respond to and recover from terrorist attacks, major disasters, or other emergencies.”

Seems like Mr. Canterbury is well suited for the committee. But he is also a registered lobbyist, according to House records. Will the White House’s “aspirations” kick Canterbury off the council? Unlikely – but the example proves just how half-baked this policy is.

Image by Flickr user mag3737, used under a Creative Commons license.

(Matthew Madia 09/30/09; 0 comments)

Transparency Provisions Wanting in New Chemical Management "Principles"

 

Yesterday the Environmental Protection Agency (EPA) revealed a set of "Essential Principles" for reforming the nation's severely flawed chemicals management policies. The principles are a helpful and welcome addition to the reform efforts, but they say little about the need for greater transparency. The six principles include calls for greater authority for EPA to set standards and the use of "sound science" to regulate chemicals – even in the face of uncertainty about their health risks.

The EPA hopes that Congress will draw on this list of principles as a guide as it crafts new legislation to reform the Toxic Substances Control Act (TSCA), the primary statute covering the more than 80,000 chemicals in commerce.

During a speech announcing the principles, the EPA administrator said, "over the years, not only has TSCA fallen behind the industry it's supposed to regulate – it's been proven an inadequate tool for providing the protection against chemical risks that the public rightfully expects."

The agency's announcement contains little guidance for Congress or the agency on dealing with the transparency of a reformed chemicals management program.

The principles contain a valuable statement calling for narrow application of a company's ability to conceal information from the public. Frequently companies submit data about chemicals that they label as confidential business information (CBI). By claiming the information is a trade secret, companies prohibit EPA from disclosing it to the public. This can deny public access to crucial information about a chemical's potential risks to public and environmental health and how those risks were determined.

The new set of principles includes this statement:

TSCA reform should include stricter requirements for a manufacturer’s claim of Confidential Business Information (CBI). Manufacturers should be required to substantiate their claims of confidentiality. Data relevant to health and safety should not be claimed or otherwise treated as CBI. EPA should be able to negotiate with other governments (local, state, and foreign) on appropriate sharing of CBI with the necessary protections, when necessary to protect public health and safety.

However, EPA's TSCA program already requires businesses to substantiate their trade secrets claims. The concern is that EPA allows non-trade secrets to slip through and information that should be disclosed is instead concealed. In response to a stakeholder's question during a conference call announcing the principles, the head of EPA's toxics office admitted that too much information was being labeled as CBI and EPA needs to make as much information available to the public as possible.

The EPA's new set of principles also declares:

Manufacturers should be required to provide sufficient hazard, exposure, and use data for a chemical to support a determination by the Agency that the chemical meets the safety standard.

This is a vital component of chemicals policy reform and it is good to see it here. Unfortunately the statement does not also include a declaration that such data be easily accessible by the public. Access to these data should be available online and not restricted to requests under the Freedom of Information Act (FOIA). Without such an affirmation of the public's right to know, the program is still susceptible to a lack of transparency.

Much to her credit, EPA administrator Lisa Jackson has already made important statements calling for greater transparency at EPA. But the statements bear repeating. Considering the high priority given to chemical management reform by the administrator, Congress, and numerous public interest groups (and even the chemical industry), the essential principles guiding this reform should not omit another call for greater transparency.

(Brian Turnbaugh 09/30/09; 1 comment)

OMB Watch Testifies before Congress

  U.S. Congress

This morning, Director of Federal Fiscal Policy Adam Hughes testified on problems with federal contracting databases before the Senate Homeland Security and Government Affairs Subcommittee on Contracting Oversight. Other witnesses included Director of Acquisition and Sourcing Management William Woods of the Government Accountability Office (GAO), Trey Hodgkins, Vice President of TechAmerica, a trade group for the technology industry, and Vivek Kundra, the Obama Administration's new Chief Information Officer. The witnesses focused on the problems a disparate and disjointed contracting database system pose to the government, watchdog groups, and contractors, and ways to fix it.

Read Adam's full testimony here>>

.

Image by Flickr user cometstarmoon used under a Creative Commons license.

(Gary Therkildsen 09/29/09; 0 comments)

Business and Anti-Regulatory Lobbyists Divided over Climate Policy

 

Increasingly, businesses are severing their ties to industry lobbying groups that oppose climate change legislation, according to an article in today’s New York Times by reporters Clifford Krauss and Kate Galbraith.

The U.S. Chamber of Commerce has been the primary target of businesses’ scorn thus far. Electric utilities Exelon and Pacific Gas & Electric have both said they will withdraw from the Chamber. Nike and Johnson & Johnson have been publicly critical of the Chamber, which is lobbying against cap-and-trade legislation currently under consideration in Congress and against EPA efforts to limit greenhouse gas emissions through regulation.

Duke Energy, historically no friend of the environment, pulled out of the National Association of Manufacturers, another industry lobbying group, and the American Coalition for Clean Coal Electricity. “It was clear that many influential members would never support climate legislation in 2009 or 2010 no matter how it was written,” Tom Williams of Duke told the Times.

In the debate over cap-and-trade legislation and the ensuing rift between the business community and the lobbyists that purport to serve them, the Chamber and others are showing their true colors: Priority number one is not working in the best interest of American businesses, it’s opposing every legislative or regulatory effort that would bring about even a modicum of positive social change. It’s dogmatic conservatism at its worst.

For years, it was difficult to distinguish between advancing the interests of business and preserving the status quo. The economy was flourishing; business was good; if it ain’t broke, don’t fix it.

But the present economic downturn has apparently reminded many business leaders of the virtue of long-term stability and sustainability. Climate change is an obvious example. Global warming is no longer perceived as a threat to only fuzzy animals and pretty flowers. Fossil fuel dependence and carbon emissions are unsustainable for everyone – people, businesses, and the American, and even global, economy.

Businesses like Exelon, Nike, and others have seen the writing on the wall. The Chamber hasn’t. Now, the lobbyists are aligned only with Congressional Republicans and many gutless centrist Democrats who are blindly resistant to change.

Even though the status quo crowd says that cap-and-trade legislation would kill the economy, it is not doing the business community any favors. From The Washington Post:

"Inaction on climate is not an option," John Rowe, Exelon's chairman and chief executive, said in a speech at an energy-efficiency conference. "If Congress does not act, the EPA will, and the result will be more arbitrary, more expensive and more uncertain for investors and the industry than a reasonable, market-based legislative solution." 

In the latest issue of OMB Watch’s biweekly e-newsletter, The Watcher, we discuss the current state of greenhouse gas reduction policy including several EPA rulemakings and a recent influential federal court ruling that will allow coal utilities to be sued for creating a public nuisance:

Polluters could increasingly feel themselves pinned between litigation and oncoming federal regulations being developed by the Obama administration. The threat of tort lawsuits and prescriptive requirements imposed by government agencies may compel polluters to reduce their carbon dioxide emissions. […]

Congress faces a choice: It could act itself by mandating a comprehensive, market-based, and tightly controlled emissions-reduction regime, or it could let EPA continue with more familiar command-and-control regulations and preserve a role for the courts, both of which would yield less predictable results.

 

Update (9.30.09): President and CEO Thomas J. Donohue defends the Chamber's position in a statement

(Matthew Madia 09/29/09; 1 comment)

GAO Recovery Act Report Confirms Impending Data Quality Issues

 

Last week, the Government Accountability Office released its third bimonthly report on the Recovery Act. The report, which examines the Act's implementation across the country, received a fair amount of press. Many of the articles focused on the speed of the Recovery Act spending, as the report noted that the spending is proceeding according to schedule, or how the report examines the effectiveness of the President's summer jobs program. Only a few articles, however, mentioned one of the most important quotes, at least in terms of Recovery Act transparency: "This unprecedented level of detailed information to be reported by a large number of recipients into a new centralized reporting system raises possible risk for the quality and reliability of these data." In other words, the GAO is very concerned about the quality of the October recipient reporting data.

Throughout the report, the GAO describes the confusion it has been hearing from the state and local level, related to the new recipient reporting requirements. Here are a few select quotes from the report, to help show what led the GAO to its conclusion (the citations are to the GAO report):

"Despite the OMB [Office of Management and Budget] and DOT [Department of Transportation] guidance, both highway and transit officials expressed concerns and challenges with meeting the recipient reporting requirements." (pg. 37)
"A number of agencies expressed confusion about calculating the number of direct jobs resulting from Recovery Act funding, especially with regard to using Recovery Act funds for purchasing equipment." (pg. 38)
"One transit agency highlighted that they had concerns about the process for calculating the number of FTEs (full-time equivalents) based on the number of hours worked on a project." (pg. 39)
"Officials from a housing industry group told us their members were not aware of the OMB guidance on recipient reports until GAO inquired about it." (pg. 98)

Yikes. Granted, this anecdotal evidence is only from two federal agencies, Transportation and Housing. However, it is not a stretch to imagine that, if these two agencies, which are handling a great deal of the stimulus funding, are having issues with reporting, then many other agencies are likely having similar problems.

Unfortunately, these reports are not too surprising. We at OMB Watch have noted the looming data quality issue before, and the previous GAO reports have said similar things as well. What makes the new GAO report newsworthy is that it is the first report to provide accounts from the ground, from the very recipients who will be reporting over the coming weeks. Hopefully, these on-the-ground reports will help convince OMB that significant reporting problems are on the horizon (to their credit, the Recovery Board, which runs Recovery.gov but cannot set reporting policy, seems to understand the impending reporting mess). If users go to Recovery.gov on October 15, expecting perfect data, then if the GAO report is to be believed, they will be very disappointed.

If there is a silver lining to this report, it's that the problem might work itself out over time. The GAO found that while many recipients are unfamiliar with the reporting requirements, those recipients who have been required to report under similar programs before seem to be less concerned than recipients who have never had to report before. As the report notes,

"While both highway and transit officials raised concerns, transit officials tended to raise more specific concerns than their highway counterparts. This may reflect differing experiences collecting this type of information. FTA [Federal Transit Administration] officials noted that recipients of transit grants have not had to collect similar information in the past." (pg. 38)

Certainly, it's not much of a silver lining, but considering how bad the reported data will likely be come October, it's good to know that there might be light at the end of the tunnel.

(Sam Rosen-Amy 09/29/09; 0 comments)

Meet the New Recovery.gov

 

...(mostly) the same as the old Recovery.gov.

The new Recovery.gov went online this morning, and it is...less than revolutionary. I've spent the morning poking around it and checking out the new features. Even though the really important stuff -- the recipient data -- will not be available until Oct. 15, I was hoping that the new site would significantly change the way Recovery watchers would be able to access Recovery spending data. This version, however, is not that site.

New Mapping Tool Front and center is a new map with which you can enter a ZIP code or click on a state to reveal contract, grant, and loan details for that geographic area. The new map is a great improvement over the previous version, but users are still unable to access or download a list of Recovery projects in their ZIP code (true, they can see them graphically on a map, but that's as far as it goes.)

Agency Spending Data There is still no relationship between the weekly agency reports and the Recovery data in USASpending.gov. Totals on each set of data do not match the other, and while this is explained as a data-entry timing issue, there is still no attempt to reconcile the two reports. I hope that come Oct. 15, recipient data will be tied to at least either USASpending.gov or the weekly agency reports. But, even within the weekly agency reports, users cannot click on a program and drill down to more specific data like contract and grant level data.

Non-Competitive Contracts While there is a special section for awarded non-competitive contracts, the list in a PDF and provides no links to further information about the contracts. In fact, the list that is in the PDF contains only the awarding agency, recipient, amount, and date signed. Without more details, like an award identification number, users are left to wander around Recovery.gov and/or USASpending.gov tracking down details of these contracts.

Contract and Grant Opportunities Contract and grant "Opportunities" are listed on the site, but their listings are only marginally useful. The Grants page contains a list of four open grants with some details, linking users to Grants.gov. (Are we to assume that there are only four Recovery Act grants available?) The Contracts page is similar, except it contains brief descriptions of exactly 50 awarded contracts and exactly 25 "up for bid" contracts (space limitations?). Although each contract listing contains a link to more details on FedBizOpps.gov, the lists are neither sortable nor searchable, not allowing users to narrow them down to save time in their searches.

Download Center There is a "Download Center" from which users can download agency reporting data (and eventually recipient data). This is actually a really nice feature. Technologically savvy users can download XML files of contract, grant, and loan data. (When I tried downloading these data this morning, the grants file was empty.) Also found in the Download Center are the weekly agency reports, but I am chagrinned to report that no improvements have been made in the weekly agency reports: They are still in agency-specific, hyperlink-free spreadsheets, rather than one master list.

The Recovery Board has added a new deck on the back of the house and put in some great landscaping, but the real questions remain: Have they repaired the foundation and fixed the plumbing? Only when recipient data come online and after the first phase of Smartronix contract expires in January will we know if this is the right house for Recovery Act transparency.

(Craig Jennings 09/28/09; 0 comments)

Politicians Influenced Device Approval, FDA Report Says

 

Responding to alleged political interference, the Food and Drug Administration will review the safety of an approved knee-injury aid.

New JerseyIn a report released yesterday, FDA employees performing an internal review of the process used to approve the device faulted “the agency's failure to respond appropriately to external pressure on decision-makers.” That pressure was exerted by the device manufacturer, ReGen, FDA political appointees, and even members of Congress.

ReGen is headquartered in New Jersey. And like any good medical product firm, it keeps a few congressmen in its pocket. Prior to the 2008 approval of the knee device, called Menaflex, FDA scientists warned it may not be safe. Then what happened, New York Times reporters Gardiner Harris and David M. Halbfinger?

But after receiving what an F.D.A. report described as “extreme,” “unusual” and persistent pressure from four Democrats from New Jersey — Senators Robert Menendez and Frank R. Lautenberg and Representatives Frank Pallone Jr. and Steven R. Rothman — agency managers overruled the scientists and approved the device for sale in December.

All four legislators made their inquiries within a few months of receiving significant campaign contributions from ReGen, which is based in New Jersey, but all said they had acted appropriately and were not influenced by the money. Dr. Andrew C. von Eschenbach, the former drug agency’s commissioner, said he had acted properly. 

Even if they all truly believe they did act properly, shouldn’t four U.S. Congressmen and the FDA commissioner be sensitive to the appearance of impropriety? No matter how you spin this story, it reeks of corruption.

The story also underscores the need to reform FDA’s expedited review process for medical devices. FDA announced this week that it has asked the Institute of Medicine to review the process, known as 510(k). Merrill Goozner at GoozNews has the full scoop.

(Matthew Madia 09/25/09; 0 comments)

Most Bundling Information Remains Undisclosed

 

After the Federal Election Commission (FEC) formulated a rule on reporting campaign contributions bundled by lobbyists, many were concerned that it was too narrow and would not quite capture very much information. Now, we see those points were not misguided. The situations under which a member of Congress is legally required to disclose a lobbyist's fundraising are limited. A recent analysis from the Associated Press found that only a few members of Congress are disclosing bundled contributions from lobbyists.

As part of the Honest Leadership and Open Government Act (HLOGA), lawmakers must report to the FEC lobbyists who have bundled money for their campaigns. A bundler collects contributions from others and then gives the money to a particular candidate.

The Sunlight Foundation has a database, Party Time!, that lists fundraisers hosted by lobbyists. "Lobbyists identified as hosts on at least 195 congressional fundraising invitations have yet to be publicly disclosed as fundraisers by the candidates who benefited, the review found. AP checked invitations that it and the nonpartisan Sunlight Foundation independently obtained against campaign finance reports filed with the Federal Election Commission and lobbyist registrations compiled by the Senate."

AP reviewed fundraisers held from March 19 through June, the first time period covered in the rules. The analysis found that there a few different ways to avoid the disclosure requirements. For example, the candidate only has to disclosure if they formally recognize the contributor as a fundraiser. In addition, someone could sponsor a fundraiser who are not themselves registered lobbyists.

(Amanda Adams 09/24/09; 0 comments)

White House "Hopes" Agencies Do Not Appoint Lobbyists to Advisory Committees

 

The White House has announced that federally registered lobbyists can not be appointed to agency advisory boards and commissions. These boards and commissions advise the federal government on policy. The White House blog post states; "Keeping these advisory boards free of individuals who currently are registered federal lobbyists represents a dramatic change in the way business is done in Washington. [. . .] While the letter of the President's Executive Order on Ethics does not apply to federally-registered lobbyists appointed by agency or department heads, the spirit does and we have conveyed that to the agencies who are responsible for these appointments." Will it really change the way business is done in Washington?

Lobbyists who are currently on advisory committees would be allowed to complete their appointment, but the agencies would have to reappoint someone who is not a federally registered lobbyist. However, it is not clear the agency has to because the White House blog post simply states, "it is our hope." Once again, we wait for some specificity and guidance, other than simply a blog posting.

The post further states; "If we are going to change the way business is done in Washington, we need to make sure we are not simply continuing the practices of the past." This seems a bit hypocritical when news reports recently discuss the nomination of Anne Ferro, a trucking industry lobbyist, to head the Federal Motor Carrier Safety Administration. No, Ferro is not nominated to an advisory committee, but it does seem to go against the "spirit" of the President's Executive Order.

Before making the formal announcement, a blog post from the Sunlight Foundation notes that "removing lobbyists from the mix will likely remove a vital source of expertise for committees. Moreover, imposing disclosure requirements only on lobbyists, and not on everyone, doesn't make a lot of sense." Sunlight offers some suggestions for ways to achieve the administration's goal of reducing conflicts of interest, such as updating the Federal Advisory Committee Act (FACA).

BNA Money and Politics ($$) reports that, "[d]uring the last Congress, the House passed a bill to reform FACA (H.R. 5687) that would have placed tighter conflict of interest disclosure requirements on advisory committee members, barred the practice of contracting out advisory duties, and extended the requirements of FACA to so-called “de-facto” committee members who do not have the right to vote."

Once again, the administration is too narrowly focused on registered lobbyists. They can just simply appoint another industry representative who is not a lobbyist. Instead, there could be more disclosure about the individuals making up the advisory committees.

(Amanda Adams 09/23/09; 0 comments)

A Few Additional Thoughts on the State Secrets Policy

 

Since my initial take on the administration’s announcement this morning of a new state secrets policy, I’ve had a chance to discuss the issue with colleagues both inside and outside of OMB Watch and have decided to briefly outline what I see as both positives and negatives of the new policy.  Ultimately, we feel the result is a net positive.

The Good:

  • The policy clearly seeks to narrow the scope of the executive privilege through application of a rigorous and formalized procedure that never existed before.  Did we really ever believe that the executive branch would give up the privilege entirely or that a president would voluntarily give up power?  A key objective of the administration seems to be to allow more cases to move forward and that can be accomplished with this policy if responsibly implemented.  This should be applauded.
  • This is the first time a president has publicly clarified the Supreme Court decision in Reynolds and thereby establishes a precedent that cannot easily be reversed by subsequent administrations without considerable public criticism.  Moreover, it gives the open government community much of what it asked for in recommendations to the Obama administration.
  • The policy includes both reporting to Congress and the requirement of referral to Inspectors General, which are the beginnings of long overdue oversight of this privilege.  Plus, the use of evidentiary materials is an important element in the new process for invoking the privilege.
  • The new process – an agency head sends evidence of need for the privilege, which is then reviewed by the Assistant Attorney General, whose recommendation is reviewed by a new State Secrets Review Panel, whose recommendation is reviewed by the Deputy Attorney General, whose recommendation is either accepted or rejected by the Attorney General – should serve to militate against unwarranted use of the privilege.

The Bad:

  • The new policy lacks clarity on judicial oversight.  It is not enough to simply imply that declarations of evidentiary support be submitted to the courts; this requirement should be spelled out and other oversight procedures should be explained.  There should be explicit opportunity for judges to review disputed document in camera, for example
  • Regular independent auditing of the entire process is needed.  Trust can only be built through verification.
  • The new standard for invoking the privilege is when disclosure could cause “significant harm” to national security.  But the term is not defined and creates too much wiggle room for an administration to abuse the privilege.
  • The policy applies only to cases that begin after Oct. 1 and does not have an impact on current or past state secrets litigation.

There are many other strengths and weaknesses to the policy – and many more will be discussed in days and weeks to come.  On balance, OMB Watch strongly commends the administration’s action. Regardless of our support, the proof is in the pudding.  The true test of this policy will be how the administration applies it from here on.  And we hope the administration continues to adjust the policy to address the weaknesses.

Finally, today’s action should not be an excuse for Congress to drop its legislative effort on narrowing the state secrets privilege and to bring greater accountability to the process.  Indeed, it should be an incentive to speed up the work and tackle the items left undone by today’s policy.

(Roger Strother 09/23/09; 0 comments)